Cargando…

Familial amyloid polyneuropathy in Portugal: New genes modulating age‐at‐onset

OBJECTIVES: Familial amyloid polyneuropathy (FAP ATTRV30M) shows a wide variation in age‐at‐onset (AO) between clusters, families, and among generations. We will now explore some candidate genes involved in altered disease pathways in order to assess their role as genetic modifiers of AO, using a fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Diana, Coelho, Teresa, Alves‐Ferreira, Miguel, Sequeiros, Jorge, Mendonça, Denisa, Alonso, Isabel, Lemos, Carolina, Sousa, Alda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288465/ https://www.ncbi.nlm.nih.gov/pubmed/28168209 http://dx.doi.org/10.1002/acn3.380

Ejemplares similares

C1QA and C1QC modify age‐at‐onset in familial amyloid polyneuropathy patients
por: Dias, Andreia, et al.
Publicado: (2019)

The hidden story behind gender differences in familial amyloid polyneuropathy (FAP) ATTRV30M
por: Santos, Diana, et al.
Publicado: (2015)

Unravelling the epidemiology of late-onset and asymptomatic carriers of FAP ATTR V30M in a Portuguese population
por: Lemos, Carolina, et al.
Publicado: (2015)

Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal
por: Inês, Mónica, et al.
Publicado: (2015)

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy
por: Lopes, Alice, et al.
Publicado: (2017)

Assessing Risk Factors for Migraine: Differences in Gender Transmission
por: Lemos, Carolina, et al.
Publicado: (2012)

Familial Amyloid Polyneuropathy treatment with Tafamidis – evaluation of one- and two-year treatment in Porto, Portugal
por: Coelho, Teresa, et al.
Publicado: (2015)

The C677T Polymorphism in MTHFR Is Not Associated with Migraine in Portugal
por: Ferro, Anabela, et al.
Publicado: (2008)

Specific ophtalmologic changes in late onset familial amyloid polyneuropathy (FAP) portuguese patients
por: Ferreira, Natalia, et al.
Publicado: (2015)

Psychopathological dimensions in familial amyloid polyneuropathy patients
por: Lopes, Alice, et al.
Publicado: (2015)

A genetic interaction of NRXN2 with GABRE, SYT1 and CASK in migraine patients: a case-control study
por: Alves-Ferreira, Miguel, et al.
Publicado: (2021)

Transthyretin familial amyloid polyneuropathy impact on health-related quality of life
por: Inês, Mónica, et al.
Publicado: (2015)

Mid- and long-term anxiety levels associated with presymptomatic testing of Huntington’s disease, Machado-Joseph disease, and familial amyloid polyneuropathy
por: Lêdo, Susana, et al.
Publicado: (2016)

Preimplantation genetic testing for familial amyloid polyneuropathy
por: Sousa, Mário
Publicado: (2022)

Interaction between γ-Aminobutyric Acid A Receptor Genes: New Evidence in Migraine Susceptibility
por: Quintas, Marlene, et al.
Publicado: (2013)

Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient
por: Seca, Mariana, et al.
Publicado: (2014)

The rehabilitation in the management of Transthyretin Familial Amyloid Polyneuropathy
por: Morier, Agnès, et al.
Publicado: (2015)

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
por: Coelho, Teresa, et al.
Publicado: (2013)

Familial Amyloid Polyneuropathy Misdiagnosed as Systemic Sclerosis
por: Pereira, Márcia Agostinho, et al.
Publicado: (2022)

Iatrogenic amyloid polyneuropathy after domino liver transplantation
por: Mnatsakanova, Diana, et al.
Publicado: (2017)

Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy
por: Romero-Imbroda, Jesús, et al.
Publicado: (2017)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy
por: Adams, David, et al.
Publicado: (2016)

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria
por: Sarafov, Stayko, et al.
Publicado: (2015)

Life paths of familial amiloidotic polyneuropathy patients: a descriptive study
por: Lopes, Alice, et al.
Publicado: (2015)

Cardiomyopathy correlates to nerve damage in p.A117S late‐onset transthyretin amyloid polyneuropathy
por: Lin, Yen‐Hung, et al.
Publicado: (2022)

Clinicopathological correlations of sural nerve biopsies in TTR Val30Met familial amyloid polyneuropathy
por: Fernandes, Armindo, et al.
Publicado: (2019)

Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H.‐J., et al.
Publicado: (2016)

“Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy
por: Conceição, Isabel, et al.
Publicado: (2016)

Maturity-Onset Diabetes of the Young (MODY) in Portugal: Novel GCK, HNFA1 and HNFA4 Mutations
por: Alvelos, Maria I., et al.
Publicado: (2020)

Inflammatory profiling of patients with familial amyloid polyneuropathy
por: Azevedo, Estefania P., et al.
Publicado: (2019)

Short Communication: Restrictions in care following the COVID-19 pandemic severely impacted Machado-Joseph disease patients: a study in the Azores Islands, Portugal
por: Couto, Daniela, et al.
Publicado: (2022)

Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy
por: González‐Duarte, Alejandra, et al.
Publicado: (2020)

Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy
por: Du, Kang, et al.
Publicado: (2021)

Deprivation-specific life tables using multivariable flexible modelling – trends from 2000–2002 to 2010–2012, Portugal
por: Antunes, Luís, et al.
Publicado: (2019)

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
por: Rousseau, Antoine, et al.
Publicado: (2015)

Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy
por: Collins, Michael, et al.
Publicado: (2018)

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H., et al.
Publicado: (2018)

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
por: Bolte, Fabian J., et al.
Publicado: (2020)

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
por: Raya-Cruz, Manuel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_km2j7095fm6d98rf88175q0jss